Resultats de la cerca - Chao, Jason

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performan... per Lingvay, Ildiko, Chao, Jason, Dalal, Mehul R., Meneghini, Luigi F.

Obtenir text complet Obtenir text complet Obtenir text complet

Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L per Zisman, Ariel, Dex, Terry, Roberts, Michelle, Saremi, Aramesh, Chao, Jason, Aroda, Vanita R.

Obtenir text complet Obtenir text complet Obtenir text complet

Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L per Zisman, Ariel, Dex, Terry, Roberts, Michelle, Saremi, Aramesh, Chao, Jason, Aroda, Vanita R.

Obtenir text complet Obtenir text complet Obtenir text complet

When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control per Umpierrez, Guillermo E., Skolnik, Neil, Dex, Terry, Traylor, Louise, Chao, Jason, Shaefer, Charles

Obtenir text complet Obtenir text complet Obtenir text complet

Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone per Trujillo, Jennifer M., Roberts, Michelle, Dex, Terry, Chao, Jason, White, John, LaSalle, James

Obtenir text complet Obtenir text complet Obtenir text complet

Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL per Dailey, George, Reid, Timothy, White, John, Chao, Jason, Zhou, Fang L., Paranjape, Sachin, Berhanu, Paulos

Obtenir text complet Obtenir text complet Obtenir text complet

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in... per Blonde, Lawrence, Bailey, Timothy S., Chao, Jason, Dex, Terry A., Frias, Juan Pablo, Meneghini, Luigi F., Roberts, Michelle, Aroda, Vanita R.

Obtenir text complet Obtenir text complet Obtenir text complet

Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study per Hassanein, Mohamed, Sahay, Rakesh Kumar, Malek, Rachid, Shaltout, Inass, Djaballah, Khier, Demil, Nacima, Chao, Jason, Andersson, Helena M, Buyukbese, Mehmet Akif, Sifri, Saud Al

Obtenir text complet Obtenir text complet